Back

Brain natriuretic peptide (BNP) level at enrolment predicts 1- and 5-year transplant-free survival in patients with pulmonary arterial hypertension (PAH): data from the REVEAL registry

30 August 2016 (14:00 - 14:10)
Organised by:
Congress Presentation Part of: Pulmonary hypertension: diagnosis, functional imaging and molecular phenotyping Chronic pulmonary hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Robert Frantz

Mayo Clinic, Rochester (United States of America)

8 More presentations in this session

Presentation thumbnail
Severe ventricular interdependence as a cause of misclassification of group 2 pulmonary hypertension
Doctor S. Rosset (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Pulmonary hypertension and pregnancy outcomes: data from the ropac study of the european society of cardiology
Doctor I. van Hagen (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Left and right ventricular peak filling rates are reduced in patients with pulmonary arterial hypertension measured with magnetic resonance imaging
Doctor C. Goransson (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Peak oxygen uptake during exercise is able to exclude scleroderma-associated pulmonary arterial hypertension with a high probability
Doctor D. Dumitrescu (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Right ventricular function in acute and chronic pulmonary hypertension using exercise cardiac magnetic resonance imaging
Doctor S. Jaijee (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension: diagnosis, functional imaging and molecular phenotyping

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources